How challenging can neuropsychiatric systemic lupus erythematous be? - experience from a tertiary care centre

被引：0

作者：

Duarte, A. C. ^{[1
]}

Silverio, Barata T. ^{[2
]}

Sousa, S. ^{[1
]}

Ribeiro, A. C. ^{[2
]}

Goncalves, P. ^{[1
]}

Cordeiro, A. ^{[1
]}

机构：

[1] Hosp Garcia de Orta, Reumatol, Almada, Portugal

[2] Hosp Garcia de Orta, Neurol, Almada, Portugal

来源：

ACTA REUMATOLOGICA PORTUGUESA | 2019年 / 44卷 / 04期

关键词：

ANTIPHOSPHOLIPID SYNDROME; COGNITIVE DYSFUNCTION; MANIFESTATIONS; ANTIBODIES; CYCLOPHOSPHAMIDE; PATHOGENESIS; MANAGEMENT; NEUROPATHY; PSYCHOSIS; DIAGNOSIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：312 / 316

页数：5

共 25 条

[1] Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus [J].

Barile-Fabris, L ;

Ariza-Andraca, R ;

Olguín-Ortega, L ;

Jara, LJ ;

Fraga-Mouret, A ;

Miranda-Limón, JM ;

de la Mata, JF ;

Clark, P ;

Vargas, F ;

Alcocer-Varela, J .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) :620-625

[2] EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs [J].

Bertsias, G. K. ;

Ioannidis, J. P. A. ;

Aringer, M. ;

Bollen, E. ;

Bombardieri, S. ;

Bruce, I. N. ;

Cervera, R. ;

Dalakas, M. ;

Doria, A. ;

Hanly, J. G. ;

Huizinga, T. W. J. ;

Isenberg, D. ;

Kallenberg, C. ;

Piette, J. C. ;

Schneider, M. ;

Scolding, N. ;

Smolen, J. ;

Stara, A. ;

Tassiulas, I. ;

Tektonidou, M. ;

Tincani, A. ;

van Buchem, M. A. ;

van Vollenhoven, R. ;

Ward, M. ;

Gordon, C. ;

Boumpas, D. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) :2074-2082

[3] ASSOCIATION BETWEEN LUPUS PSYCHOSIS AND ANTI-RIBOSOMAL P PROTEIN ANTIBODIES [J].

BONFA, E ;

GOLOMBEK, SJ ;

KAUFMAN, LD ;

SKELLY, S ;

WEISSBACH, H ;

BROT, N ;

ELKON, KB .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :265-271

[4] Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus [J].

Bortoluzzi, Alessandra ;

Scire, Carlo Alberto ;

Bombardieri, Stefano ;

Caniatti, Luisa ;

Conti, Fabrizio ;

De Vita, Salvatore ;

Doria, Andrea ;

Ferraccioli, Gianfranco ;

Gremese, Elisa ;

Mansutti, Elisa ;

Mathieu, Alessandro ;

Mosca, Marta ;

Padovan, Melissa ;

Piga, Matteo ;

Tincani, Angela ;

Tola, Maria Rosaria ;

Tomietto, Paola ;

Valesini, Guido ;

Zen, Margherita ;

Govoni, Marcello .

RHEUMATOLOGY, 2015, 54 (05) :891-898

[5] Chorea in the antiphospholipid syndrome - Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature [J].

Cervera, R ;

Asherson, RA ;

Font, J ;

Tikly, M ;

Pallares, L ;

Chamorro, A ;

Ingelmo, M .

MEDICINE, 1997, 76 (03) :203-212

[6] Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study [J].

Cui, H-W ;

Lei, R-Y ;

Zhang, S-G ;

Han, L-S ;

Zhang, B-A .

LUPUS, 2019, 28 (08) :961-969

[7]

D'Cruz DP, 2004, J RHEUMATOL, V31, P280

[8] Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment [J].

de Amorim, L. C. D. ;

Maia, F. M. ;

Rodrigues, C. E. M. .

LUPUS, 2017, 26 (05) :529-536

[9] Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus [J].

Denburg, SD ;

Denburg, JA .

LUPUS, 2003, 12 (12) :883-890

[10] Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): Clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis [J].

Giorgi, D ;

Gabrieli, CB .

CLINICAL RHEUMATOLOGY, 1999, 18 (02) :124-131

← 1 2 3 →